Druga obavijest BOOK_kb:10x21

Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 1
1. regionalni kongres / 1st Regional Congress
Edukacija i znanost u onkologiji
Education and Research in Oncology
DRUGA OBAVIJEST
/ SECOND ANNOUNCEMENT
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 2
Organizatori
Zaklada onkologija, Hrvatska i National Cancer Institute’s Center for
Global Health, US u suradnji s Hrvatskim društvom za internističku on­
kologiju, Hrvatskim društvom za endokrinološku onkologiju, Onkolo­
ško­hematološkim društvom Hrvatske udruge medicinskih sestara,
Hrvatskim društvom inženjera medicinske radiologije
Organizers
Oncology Foundation, Croatia and National Cancer Institute’s Center
for Global Health, US in cooperation with Croatian Society of Medical
Oncology, Croatian Society of Endocrine Oncology, Croatian Nurses As­
sociation ­ Society of Oncology and Hematology, Croatian Society of
Medical Radiology Engineers
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 3
1. regionalni kongres / 1st Regional Congress
Edukacija i znanost u onkologiji
Education and Research in Oncology
Hotel Sheraton, Zagreb, Hrvatska / Croatia
20.­23.11.2013. / November 20-23, 2013
DRUGA OBAVIJEST
/ SECOND ANNOUNCEMENT
pod visokim pokroviteljstvom predsjednika Republike Hrvatske i
Ministarstva zdravlja Republike Hrvatske
/
under the auspices of the President of the Republic of
Croatia and the Ministry of Health of the Republic of Croatia
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 4
1. regionalni kongres
Edukacija i znanost u onkologiji
4
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 5
U posljednjih desetak godina koncept translacijske medicine je
od modela medicine budućnosti postao svakodnevicom svih
uključenih u liječenje bolesnika s rakom. To liječnike koji liječe
bolesnike s rakom suočava s brojnim novim izazovima. Jedan
od njih je i potreba dobrog poznavanja, razumijevanja i svakod­
nevnog praćenja širokog polja istraživanja koje obuhvaća naj­
različitije aspekte biologije raka i različite eksperimentalne
pristupe njegovu liječenju. U situaciji preopterećenosti svakod­
nevnom skrbi za velik broj bolesnika, taj se izazov ponekad čini
nesavladivim. Međutim, alternativa je pružanje neadekvatne
skrbi bolesnicima što se ne smije prihvatiti. Jedini način da bo­
lesnicima osiguramo i pružimo najkvalitetniju moguću skrb, što
nam je osnovna zadaća oko koje ne bi smjelo biti kompromisa,
jest biti upućen u rezultate najnovijih istraživanja i metoda u
području biologije i liječenja raka.
Upravo to je osnovni cilj ovog kongresa, a jedan od glavnih na­
glasaka čitavog kongresa i većine predavanja bit će na primjeni
rezultata novih istraživanja u svakodnevnoj praksi liječenja bo­
lesnika s rakom. Osim samih predavanja, kongres će omogućiti
upoznavanje i povezivanje kolega iz brojnih ustanova i zemalja
regije sa svjetskim stručnjacima, posebice onima iz SAD­a koji
će sudjelovati u većem broju s obzirom na to da je NCI Center
for Global Health suorganizator kongresa. O značaju, iskustvima
i načinima provođenja edukacije u onkologiji raspravit će se na
okruglom stolu na kojem će, uz regionalne, sudjelovati i europ­
sko­američki predstavnici.
U program kongresa uklopljeni su i programi za medicinske sestre i radiološke tehnologe bez čije suradnje nije moguće osigu­
rati dobru skrb onkoloških bolesnika.
Radostan sam što su ugledni stručnjaci i znanstvenici iz NCI po­
zitivno ocijenili program te pristali biti suorganizatorima prvog
regionalnog kongresa „Edukacija i znanost u onkologiji“. Uvje­
ren sam da će važnost i aktualnost tema, kvaliteta voditelja te­
matskih blokova i predavača, kao i domaćinstvo hrvatske
metropole biti opravdanim razlogom vašeg sudjelovanja. Zasi­
gurno će i predstavnici farmaceutskih tvrtki pronaći svoj interes
i način sudjelovanja na ovom skupu.
Konačni ocjenjivači uspješnosti ovog kongresa bit će naši bole­
snici, jer glavni cilj ovog sastanka jest bolja skrb za bolesnike s
rakom.
Veselimo se susretu u Zagrebu,
Predsjednik Kongresa i Zaklade onkologija
Mirko Šamija
5
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 6
1st Regional Congress
Education and Research in Oncology
6
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 7
Over the past decade, the concept of translational medicine, what was
once a model for the future, has become daily life of all involved in can­
cer treatment. This makes cancer treating doctors face an array of new
challenges. Among them is the necessity of having good knowledge,
understanding and keeping up to date with this broad field of research
that covers myriad aspects of cancer biology and various experimental
approaches to cancer treatment. In a situation where being over­
loaded with daily caregiving to a large number of patients, this chal­
lenge sometimes seems unsurmountable. However, the alternative is
then inadequate care for cancer patients which must not be accepted.
The only way to ensure and provide the best care possible to every
patient, what is our essential duty and responsibility that permits no
compromises, is to keep doctors informed of current clinical trial re­
sults and methods in the field of cancer biology and therapy.
This is actually the primary goal of this Congress, and one of the main
points of the entire Congress and most of presentations will be on im­
plementing recent results of clinical trials in daily care for cancer pa­
tients. In addition to presentations, there will be opportunities for
discussion among colleagues from many institutions and countries of
the Region and world experts in the field, particularly those from the
United States who will be largely represented since the NCI’s Center
for Global Health is a co­organizer of this Congress. The significance,
experiences and ways of conducting oncology education programs
will be discussed at a Roundtable Session involving participants from
the Region as well as representatives from other European countries
and the United States.
The Congress program also incorporates appropriate programs for
both nurses and radiologic technologists without whose cooperation
it would be impossible to provide quality care for patients with cancer.
I am happy that renowned experts and scientists from the National
Cancer Institute have given our program a positive opinion and agreed
to collaborate on this First Regional Congress on “Education and Re­
search in Oncology”. I am confident that the importance and up­to­
dateness of the topics, quality session chairs and presenters, as well
as hostmanship of the Croatian capital will be good enough reasons
to encourage your attendance. Pharmaceutical industry representa­
tives too will undoubtedly see the relevance to their own interests and
find the appropriate form of their participation in this meeting.
Eventually, the Congress’ success will be measured by our patients,
since improving the care of cancer patients is the primary objective
of our meeting.
I look forward to meeting you in Zagreb,
Congress and Oncology Foundation Chairman
Mirko Šamija
7
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 8
Predsjednik Kongresa / Congress Chairman
Mirko Šamija
Organizacijski odbor / Organizing Committee
Predsjednik / Chairman: Borislav Belev
Tajnice / Secretaries: Marija Strnad, Morana Šimat
Članovi / Members: Milenko Bevanda, Damir Ciprić, Dinko Čović,
Renata Dobrila Dintinjana, Velibor Drakulić, Katja Fidler Klepac,
Marko Jakopović, Jadranka Lakičević, Slavko Lovasić, Gordana
Mamić, Jure Murgić, Steven Z. Pavletic, Dražen Pulanić, Milan
Risteski, Branka Svetec, Ivan Šamija, Dino Tarabar, Ted Trimble
Znanstveni odbor / Scientific Committee
Predsjednik / Chairman: Steven Z. Pavletic
Članovi / Members: Antonija Balenović, Mario Cindrić, Tanja Čufer,
Ana Fröbe, Igor Fučkan, Lee Helman, Velimir Karadža, Željko
Kaštelan, Helena Medvedec, Marica Miščančuk, Damir Nemet,
Slobodanka Ostojić, Julio Pirović, Stjepko Pleština, Tatjana
Poljičanin, Igor Stojkovski, Božena Šarčević, Ilijan Tomaš, Ted
Trimble, Kristian Vlahoviček, Siniša Volarević, Damir Vrbanec,
Milan Vrkljan
Počasni odbor / Honorary Committee
Predsjednik / Chairman: Rajko Ostojić
Članovi / Members: Tome Antičić, Zlata Čanić, Ivan Đikić, Vida
Demarin, Hedvig Hricak, Branimir Jakšić, Jacek Jassem, Anica
Jušić, Zvonko Kusić, Boris Labar, Rusmir Mesihović, Luka Milas,
Michael Molls, Marko Pećina, Robert Pirker, Ivan Prpić, Branimir
I. Sikic, Mirna Šitum
Stručni program Kongresa / Congress Program
Pozvana predavanja / Invited Keynote Presentations
Okrugli stol / Round Table
Posebni simpozij / Special Symposium
Usmeni prikazi izabranih postera / Oral Presentation of Se­
lected Posters
Satelitski simpoziji / Satellite Symposia
8
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 9
Teme / Topics
• Genomika i proteomika raka / Cancer Genomics and Proteomics
• Matične stanice raka / Cancer Stem Cells
• Edukacija u onkologiji: regionalna i svjetska iskustva / Oncology Education: Regional and World Experiences
• Heterogenost raka i razvoj rezistencije na terapiju / Cancer
Heterogeneity and Development of Resistance to Therapy
• Imunoterapija raka / Cancer Immunotherapy
• Prikaz kliničkih istraživanja (faze I/II/III), perspektive novih
terapijskih mogućnosti / Review of Recent Clinical
Trials (Phase I/II/III), Prospects for New Therapeutic Options
• Imunoterapija raka / Cancer Immunotherapy
• Zloćudne hematološke bolesti: ogledni primjer napretka u on­
kologiji / Hematological Malignancies: A Paradigm for Advances in Oncology
Za medicinske sestre / for Nurses
• Etičke dileme u onko­hematologiji / Ethical Dilemmas in
Hematology/Oncology Nursing
• Ekstravazacija citotoksičnih lijekova / Extravasation of
Cytotoxic Drugs
• Hitna stanja u onkologiji i hematologiji /
Hematology/Oncology Emergencies
• Jatrogene bolesti u sestrinskoj praksi / Iatrogenic Disorders
in Nursing Practice
• Edukacija pacijenata na peroralnoj terapiji / Education of
Patients on Peroral Therapy
• Slobodne teme / Free Topics
Za radiološke tehnologe / for Radiologic Technologists
• Radiologija / Radiology
• Magnetna rezonancija / Magnetic Resonance Imaging
• Radioterapija / Radiation Therapy
• Nuklearna medicina / Nuclear Medicine
Službeni jezici: hrvatski i engleski
(bez simultanog prevođenja) /
Official languages: Croatian and English
(no simultaneous interpretation)
Tehnički organizator / Technical organizer:
O­Tours d.o.o.
Gajeva 6, HR­10000 Zagreb, Hrvatska
MB 1212397
tel. +385 1 4831 444 , mobile +385 98 9805 716
fax + 385 1 4813 013
e­mail: [email protected]; [email protected]
www.otours.hr
www.zaklada-onkologija.hr
9
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 10
Preliminarni program / Preliminary Program
10
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 11
Srijeda, 20.11.2013. / Wednesday, Nov 20, 2013
16:00 ­ 20:00
Registracija sudionika / Registration
18:00 ­ 18:15
Svečano otvorenje / Opening Ceremony
18:00 ­ 18:15 Plenarno predavanje / Plenary Lecture
Lee Helman (SAD / USA): Genomika raka i precizna medicina u
21. stoljeću / Cancer Genomics & Precision Medicine in the
21st Century
18:45 ­ 19:15 Video snimka predavanja / Video Lecture
Branimir I. Sikic (SAD / USA): Ciljana antitumorska terapija: izazovi i mogućnosti / Targeted Anticancer Therapies: Challenges
and Opportunities
19:15
Koktel dobrodošlice / Welcome Cocktail Reception
Četvrtak, 21.11.2013. / Thursday, Nov 21, 2013
9:00 ­ 11:00
Genomika i proteomika raka / Cancer Genomics
and Proteomics
Voditelj / Chair: Ivan Šamija
Ivan Šamija (Hrvatska / Croatia): uvod / Introduction
Lina Zgaga (Irska / Ireland): Cjelogenomske studije povezanosti:
na primjeru kolorektalnog raka / Genome-Wide Association
Studies: Lessons from Colorectal Cancer
Kristian Vlahoviček (Hrvatska / Croatia): Računalna biologija i genomika - novi pristupi u proučavanju života / Computational
Biology and Genomics - The New Approaches to the Study of Life
Vessela N. Kristensen (Norveška / Norway): Integrirana analiza
raka dojke otkriva razlike u vaskularnim i interleukinskim signalnim putevima / Integrated Analysis of Breast Cancer Reveal Differential Vascular and Interleukin Signaling
Mario Cindrić (Hrvatska / Croatia): Medicinska proteomika u onkologiji / Medical Proteomics in Oncology
11:00 ­ 11:15
Stanka / Coffee Break
11:15 ­ 11:45
SATELITSKI SIMPOZIJ / SATELLITE SYMPOSIUM
11:45 ­ 13:15 Matične stanice raka / Cancer Stem Cells
Voditeljica / Chair: Božena Šarčević
Božena Šarčević (Hrvatska / Croatia): uvod / Introduction
Marija Balić (Austrija / Austria): Matične stanice raka i metastaze:
važnost za nove terapijske pristupe / Cancer Stem Cells and Metastases: Relevance for Novel Therapeutic Approaches
11
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 12
Ana Gašparović Čipak (Hrvatska / Croatia): Interakcija oksidativnog stresa i izvanstaničnog matriksa određuju sudbinu matičnih stanica raka / Interaction of Oxidative Stress and Extracellular Matrix Modulates Cancer Stem Cell Fate
Sanda Šitić (Hrvatska / Croatia): Utjecaj kroničnog stresa i doksorubicina na matične stanice raka dojke / The Influence of
Chronic Stress and Doxorubicin on Breast Cancer Stem Cells
13:15 ­ 14:00
Ručak / Lunch
14:00 ­ 15:00
Plenarna predavanja / Plenary Lectures
Primož Strojan (Slovenija / Slovenia): Onkološka edukacija u Sloveniji / Oncology Education in Slovenia
Damir Vrbanec (Hrvatska / Croatia): Edukacija u području internističke onkologije u Hrvatskoj / Medical Oncology Education
in Croatia
15:00 ­ 18:30 Okrugli stol / Roundtable Session
Edukacija u onkologiji: regionalna i svjetska iskustva /
Oncology Education: Regional and World Experiences
Voditelj / Chair: Steven Zivko Pavletic, Mirko Šamija
15:00 ­ 16:15
Prvi dio / First Part
15:00 ­ 15:15 Boris Labar (Hrvatska/Croatia): Onkološka edukacija u dodiplomskoj i postdiplomskoj nastavi i hematološkoj
specijalizaciji u Hrvatskoj / Oncology Education in Undergraduate, Postgraduate and Hematology Residency Training Programs in Croatia
15:15 ­ 15:25 Josip Grah (Hrvatska/Croatia): Onkološka edukacija u radioterapijskoj specijalizaciji u Hrvatskoj / Oncology Education in Radiation Therapy Residency Programs in Croatia
15:25 ­ 15:35 Ivan Milas (Hrvatska/Croatia): Onkološka edukacija u kirurškim specijalizacijama u Hrvatskoj / Oncology
Education in Surgical Residency Programs in Croatia
15:35 ­ 15:45 Milica Katić (Hrvatska/Croatia): Onkološka edukacija u obiteljskoj medicini u Hrvatskoj / Oncology Education
in Family Medicine in Croatia
15:45 ­ 15:55 Renata Dobrila Dintinjana (Hrvatska/Croatia): Trajna onkološka edukacija u Hrvatskoj / Continuing Oncology
Education in Croatia
15:55 ­ 16:05 Antonija Balenović (Hrvatska/Croatia): Uloga inerneta u onkološkoj edukaciji / The Role of Internet in Oncology
Education
16:05 ­ 16:15 Zdenko Sonicki (Hrvatska/Croatia): Uloga statistike u onkološkoj edukaciji / The Role of Statistics in Oncology Education
16:15 ­ 16:30
Stanka / Cofee Break
16:30 ­ 18:30
Drugi dio / Second Part
16:30 ­ 16:40 Milenko Bevanda (BiH/B&H): Onkološka edukacija u BiH / Oncology Education in Bosnia and Herzegovina
12
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 13
16:40 ­ 16:50 Igor Stojkovski (Makedonija/Macedonia): Onkološka edukacija u Makedoniji / Oncology Education in Macedonia
16:50 ­ 17:00 Dino Tarabar (Srbija/Serbia): Onkološka edukacija u Srbiji / Oncology Education in Serbia
17:00 ­ 17:15 Lee Helman (SAD/USA): Onkološka edukacija u
SAD sa stajališta NCI-a / Oncology Education in the US – from
the NCI's Standpoint
17:15 ­ 17:30 Antoinette Tan (SAD/USA): Onkološka edukacija
u SAD sa stajališta ASCO-a / Oncology Education in the US –
from the ASCO's Standpoint
17:30 ­ 17:45 Tanja Čufer (Slovenija/Slovenia): Klinička istraživanja u EU: prepreke i izazovi / Barriers and Challenges to Clinical Research in EU
17:45 ­ 18:00 Siniša Volarević (Hrvatska/Croatia): Iskustva s FP
7 EU projektima iz područja onkologije / Experience with EU
Funded Oncology-Related Projects
18:00 ­ 18:10 Steven Zivko Pavletic (SAD/USA): Aktivnosti NCIa u Istočnoj Europi / NCI Activities in Eastern Europe
18:10 ­ 18:30 Rasprava / Discussion
Petak, 22.11.2013. / Friday, Nov 22, 2013
9:00 ­ 10:30
Heterogenost raka i razvoj rezistencije na terapiju / Cancer Heterogeneity and Development of Resistance to
Therapy
Voditelj / Chair: Borislav Belev
Borislav Belev (Hrvatska / Croatia): uvod / Introduction
Ana Kulić (Hrvatska / Croatia): Značenje in vitro ispitivanja kemosenzitivnosti tumora / Significance of In Vitro Cancer Chemosensitivity Studies
Borislav Belev (Hrvatska / Croatia): Farmakogenomika u onkologiji danas / Pharmacogenomics in Oncology Today
Robert Likić (Hrvatska / Croatia): „Multidrug resistance" – mehanizmi nastanka i klinički primjeri / Multidrug Resistance –
Mechanisms of Development and Clinical Examples
10:30 ­ 11:30
Stanka / Coffee Break
11:30 ­ 12:30
Plenarna predavanja / Plenary Lectures
11:30 ­ 12:00 Michael Molls (Njemačka / Germany): Edukacija
u području radioterapijske onkologije u Njemačkoj / Education in Radiation Oncology in Germany
12:00 ­ 12:30 Ivan Đikić (Njemačka / Germany): Uloga Ubikvitina u razvoju tumora / Ubiquitin Networks in Regulation of
Cancer Pathogenesis
12:30 ­ 13:30
Ručak / Lunch
Razgledavanje postera u prisutnosti autora / Poster viewing
with authors present
13
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 14
13:30 ­ 17:30 Prikaz kliničkih istraživanja faze I/II/III i perspektive novih terapijskih mogućnosti / Review of Recent Clinical Trials (Phase I/II/III), Prospects for New Therapeutic
Options
Voditelji / Chairs: Renata Dobrila Dintinjana i Damir Vrbanec
Postignuća proizašla iz kliničkih ispitivanja u tijeku / New Developments with Ongoing Clinical Research
• rak pluća / Lung Cancer
Robert Pirker (Austrija / Austria): Rak pluća: najnoviji pomaci u liječenju i specifični problemi u Srednjoj Europi
/ Lung Cancer: Recent Therapeutic Advances and Specific Issues in Central Europe
• rak dojke / Breast Cancer
Antoinette Tan (SAD / USA): Trostruko negativan rak
dojke / Triple-Negative Breast Cancer
Tanja Čufer (Slovenija / Slovenia): Hormonski ovisan i
HER2-pozitivan rak dojke / Hormone-Dependent and
HER2-Positive Breast Cancer
• rak prostate / Prostate Cancer
William Dahut (SAD / USA): Budući lijekovi za uznapredovali rak prostate / Emerging Therapies in Advanced Prostate Cancer
15:30 ­ 15:45
Stanka / Coffee Break
• kolorektalni rak / Colorectal Cancer
Michael Pishvaian (SAD / USA): Novi terapijski postupci za
bolesnike s uznapredovalim kolorektalnim rakom /
Novel Therapies for Patients with Advanced Colorectal
Cancer
• drugi tumori probavnog sustava / Other GI Tumors
Dino Tarabar (Srbija / Serbia)
• potporna skrb / Supportive Care
Renata Dobrila Dintinjana (Hrvatska / Croatia)
17:15 ­ 17:30
Stanka / Coffee Break
17:30 ­ 18:30 Plenarno predavanje / Plenary Lecture
Nancy Hardy (SAD / USA): Cancer Immunotherapy
14
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 15
Subota, 23.11.2013. / Saturday, Nov 23, 2013
8:30 ­ 11:15 Posebni simpozij / Special Symposium
Zloćudne hematološke bolesti: Ogledni primjer napretka u onkologiji / Hematological Malignancies: A Paradigm for Advances
in Oncology
Voditelji / Chairs: Damir Nemet, Srđan Verstovšek
8:30 ­ 8:55 Plenarno predavanje / Plenary Lecture
Srđan Verstovšek (SAD / USA): Moć inhibicije Janus kinaze 2
(JAK2) kod zloćudnih hematoloških bolesti / The Power of
JAK2 Inhibition in Hematological Malignancies
Simpozijska izlaganja / Symposium Presentations
8:55 ­ 9:20 Dubravka Sertić (Hrvatska / Croatia): Imatinib mesilat – prvi ali ne i posljednji: napredak u inhibiciji tirozin-kinaze / Imatinib Mesilat - the First but Not the Last: Advances
in Thyrosine Kynase Inhibition
9:20 ­ 9:45 Damir Nemet (Hrvatska / Croatia): Dalje od citotoksične terapije multiplog mijeloma: imunomodulatorni agensi
i inhibitori proteasoma / Beyond Cytotoxic Therapy in Multiple
Myeloma: Immunomodulatory Agents and Proteasome Inhibitors
9:45 ­ 10:10 Igor Aurer (Hrvatska / Croatia): Monoklonska protutijela: od revolucije do evolucije / Monoclonal Antibodies:
From Revolution to Evolution
10:10 ­ 10:35 Slobodanka Ostojić Kolonić (Hrvatska / Croatia):
Važnost epigenetskih promjena: DNK demetilacijska sredstva
i inhibitori histon deacetilaze / The Importance of Epigenetic
Changes: DNA Demethylating Agents and Hystone Deacethylase Inhibitors
10:35 ­ 11:00 Jelena Roganović (Hrvatska / Croatia): Važnost detekcije i praćenja ostatne bolesti kod leukemija / The Importance of Detection and Monitoring of Residual Disease in
Leukemia
11:00 ­ 11:15 Rasprava / General Discussion
11:15 ­ 11:30
Stanka / Coffee Break
11:30 ­ 12:00 Plenarno predavanje / Plenary Lecture
Peter Valent (Austrija / Austria): Definicija, terminologija i klasifikacija matičnih stanica raka / Definition, Terminology and
Classification of Neoplastic Stem Cells
12:15 ­ 13:00 Prikaz izabranih postera, dodjela nagrada / Oral
Presentation of Selected Posters, Announcement of Awards
13:00
Zatvaranje Kongresa / Closing Ceremony
15
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 16
Program za medicinske sestre / Program for Nurses
u organizaciji
Onkološko – hematološkog društva Hrvatske udruge
medicinskih sestara /
organized by the
Croatian Nurses Association – Society of Oncology and
Hematology
16
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 17
Poštovane kolegice i kolege, dame i gospodo,
veliko nam je zadovoljstvo pozvati Vas na naše tradicionalno
druženje onko­hematologije u kojem želimo razvijati i pobolj­
šati profesionalna znanja i vještine u sestrinskoj praksi.
Potaknuti prethodnim zajedničkim skupovima o potpornom li­
ječenju, cilj ovog kongresa je učinkovita razmjena multikultur­
nih stajališta i pogleda na sestrinstvo današnjice i u regijama
koje nas okružuju.
Kako prepoznati hitna stanja i nuspojave liječenja, etičke dileme
i načini edukacije pacijenata naše su teme u kojima će se naći
prostora za sve sudionike.
Zajednički interesi, nove spoznaje, kontinuirano poboljšanje i
razvijanje profesionalnih znanja i vještina imat će važno mjesto
u povijesti Onkološko­hematološkog društva medicinskih se­
stara, a Vaše aktivno sudjelovanje pridonijet će uspješnijem
ostvarenju ovog programa.
Radujemo se susretu s Vama!
Predsjednica Onkološko­hematološkog društva
Branka Svetec
Dear Colleagues, Ladies and Gentlemen,
It is our great pleasure to invite you to join us for our traditional
hematology/oncology gathering to further develop and advance
professional knowledge and skills required in nursing practice.
Inspired by our previous meetings on supportive care, this con­
ference is aimed at a fruitful exchange of our multicultural atti­
tudes and views on today’s nursing in neighboring regions.
How to recognize emergencies and therapy side effects, ethical
dilemmas and patient education models are the topics we will
share with all the participants.
Mutual interests, new information, continuous improvement
and development of professional knowledge and skills will rank
high in the history of our Society of Oncology and Hematatology,
and your active participation is the key to successful accom­
plishment of this program.
We look forward to seeing you soon,
Society of Oncology and Hematology Chairperson
Branka Svetec
17
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 18
Preliminarni program / Preliminary Program
18
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 19
Srijeda, 20.11 – subota, 23.11.2013. /
Wednesday, Nov 20 – Saturday, Nov 23, 2013
Etičke dileme u onko-hematologiji / Ethical Dilemmas in
Hematology/Oncology Nursing
Voditeljice / Chairs: Marica Miščančuk, Nevenka Stančić
Ekstravazacija citotoksičnih lijekova / Extravasation of
Cytotoxic Drugs
Voditeljice / Chairs: Božena Kapitarić, Ljiljana Pomper, Štefanija
Pintarić
Hitna stanja u onkologiji i hematologiji / Hematology/Oncology Emergencies
Voditeljice / Chairs: Vesna Družinić, Đurđica Zlodi, Gordana
Mamić
Jatrogene bolesti u sestrinskoj praksi / Iatrogenic Disorders in Nursing Practice
Voditeljice / Chairs: Dijana Dautović, Ana Ljubić, Marija Schon­
berger
Okrugli stol - Edukacija pacijenata na peroralnoj terapiji /
Roundtable Session – Education of Patients on Peroral
Therapy
Voditeljice / Chairs: Branka Svetec, Silvija Piškorijanec, Vesna
Družinić
Slobodne teme / Free Topics
Voditeljice / Chairs: Renata Cerar, Jasminka Miličević
19
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 20
Program za radiološke tehnologe / Program for Radiologic
Technologists
u organizaciji Hrvatskog društva inženjera medicinske
radiologije /
organized by the Croatian Society of Medical Radiology
Engineers
20
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 21
Medicina i znanost grabi velikim koracima i traži od nas, radio­
loških tehnologa, neke nove vještine i znanja. Pruža nam se pri­
lika da, nedugo nakon skupa u Zadru, nastavimo raspravu o
vještinama i znanjima, sposobnosti prosudbe stavova i vrijed­
nosti profesije radiološkog tehnologa u svim područjima našeg
rada. Važnost ove teme je potreba usklađenja profesije s Direk­
tivom 2005/36/EC.
U uvodu ćemo se podsjetiti na opće, zajedničke kompetencije,
a zatim Vas pozivam da nam se pridružite u raspravama po blo­
kovima u kojima ćemo raspravljati o specifičnim poslovima ra­
diološke tehnologije, radioterapijske tehnologije i tehnologije
nuklearne medicine.
Kako bismo pružili cjelovitu sliku profesije, pozvat ćemo pred­
stavnike visokoškolskih ustanova u Republici Hrvatskoj da nam,
uz tematske blokove kao i u raspravi na okruglom stolu, prikažu
viziju školovanja radioloških tehnologa u svjetlu novonastalih
okolnosti ulaskom u Europsku uniju.
Damir Ciprić
Medicine and science are taking big steps forward and require
of radiologic technologists to acquire new skills and knowledge,
too. Shortly after our conference in Zadar, there is a new oppor­
tunity to continue our discussion on skills and knowledge, abil­
ity to assess the attitudes and values of the radiologic
technology profession in any field of our work. The importance
of this topic lies in recognition of the need for harmonization of
our professional standards with the Directive 2005/36/EC.
After an introduction that will help us recall any common and
shared competency, I invite you to join discussion sessions on
specific tasks involved in careers in radiologic technology, radi­
ation therapy technology and nuclear medicine technology.
In order to get a complete picture of this profession, we will in­
vite representatives from Croatian institutions of higher educa­
tion to join our topic sessions and roundtable discussion and
present their vision of training for radiologic technologists in
the light of recent circumstances of Croatia’s accession to the
European Union.
Damir Ciprić
21
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 22
Preliminarni program / Preliminary Program
22
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 23
Petak, 22.11.2013. / Friday, Nov 22, 2013
8:00 ­ 9:00
Prijava sudionika / Registration
9:00
Pozdrav sudionicima programa za radiološke
tehnologe / Welcome Address to Attendees of the Radiologic
Technologists Program
Uvodna riječ / Introductory Address by – Damir Ciprić
9:15 - 11:00 1. BLOK – Radiologija / Session 1: Radiology
Voditelji / Chairs: Maja Karić, Julio Pirović
Uvodno predavanje / Introductory Presentation by Julio Pirović
Prikaz edukativnih programa (tečajevi) / Review of Educational
Programs (Training Courses)
Prikaz mogućeg stručnog i znanstavenog doprinosa / Review
of Potential Professional and Scientific Contributions
11:00 ­ 11:30 Stanka / Coffee Break
11:30 - 13:00 2. BLOK – Magnetna rezonancija / Session 2:
Magnetic Resonance Imaging
Voditelj / Chair: Igor Fučkan
Uvodno predavanje / Introductory Presentation by Igor Fučkan
Prikaz edukativnih programa (tečajevi) / Review of Educational
Programs (Training Courses)
Prikaz mogućeg stručnog i znanstavenog doprinosa / Review
of Potential Professional and Scientific Contributions
13:00 ­ 14:30 Stanka za ručak / Lunch Break
14:30 - 16:00 3. BLOK – Radioterapija / Session 3: Radiation Therapy
Voditelji / Chairs: Miran Gašparović, Velimir Karadža
Uvodno predavanje / Introductory Presentation
Prikaz edukativnih programa (ESTRO) / Review of Educational
Programs (ESTRO)
Prikaz mogućeg stručnog i znanstavenog doprinosa / Review
of Potential Professional and Scientific Contributions
16:00 ­ 16:30 Stanka / Coffee Break
16:30 - 17:30 4. BLOK – Nuklearna medicina / Session 4:
Nuclear Medicine
Voditeljica / Chair: Helena Medvedec
Uvodno predavanje / Introductory Presentation
Prikaz edukativnih programa / Review of Educational Programs
Prikaz mogućeg stručnog i znanstavenog doprinosa / Review
of Potential Professional and Scientific Contributions
17:30
Okrugli stol / Roundtable Session
Edukacija / specijalizacije / diplomski studij / Education / Spe­
cific Training Courses / Graduate Study Programs
23
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 24
Pozvani predavači / voditelji tematskih cjelina / sudionici
okruglog stola
Invited Speakers / Session Chairs / Round Table Participants
Pozvani predavači, voditelji tematskih cjelina i sudionici okru­
glog stola oslobođeni su plaćanja kongresnih kotizacija i hotel­
skog smještaja, ali su obvezni pravovremeno popuniti i dostaviti
tehničkom organizatoru formular za prijavu smještaja.
All invited speakers, session chairs and round table participants,
who receive their registration and hotel accommodation free of
charge, are required to fill out the accommodation form and submit the completed form to the Technical Organizer.
Posteri / Poster Information
Pozivamo liječnike, medicinske sestre i radiološke tehnologe da
prijave postere na navedene teme i prikažu rezultate postignute
u kliničkom i istraživačkom radu.
Doctors, nurses and radiologic technologists are encouraged to
submit their poster abstracts on the listed topics showing the results derived from their clinical experience and research studies.
Dimenzije stalaka za postere / Poster board size: 120 x 100 cm
(visina/height x širina/width)
Postavljanje postera 21.11.2013. / Skidanje postera 23.11.2013.
Poster set-up Nov 21, 2013 / Poster dismantling Nov 23, 2013
Upute za pisanje sažetaka / Abstract Information
Sažeci predavanja i sažeci postera, po mogućnosti veličine 250­
500 riječi, pisani jednostrukim proredom, trebaju sadržavati
naslov, autore (puno ime i prezime), adresu ustanove te kratak
sadržaj. Sažeci se šalju na e­mail adrese [email protected] i [email protected].
Both invited speaker abstracts and poster abstracts of 250-500
words should be typed single-spaced and include the Title, Author(s) (full first name and last name), Institutional Affiliation,
Address, and Body of Abstract. Abstracts are to be submitted via
e-mail at [email protected] and [email protected].
24
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 25
Produženi rok za prijavu sažetaka: 1.10.2013. /
Extended Deadline for Abstract Submission: October 1, 2013
Pravodobno pristigli sažeci bit će objavljeni u knjizi sažetaka.
Sve sažetke za postere pregledat će članovi Znanstvenog odbora
i izabrati najzanimljivije za kratak usmeni prikaz (5 minuta) na
Kongresu. Tri najbolja postera bit će novčano nagrađena.
Abstracts received by the announced deadline will be published
in the Congress Book of Abstracts. All abstracts will be reviewed
by the Scientific Committee to select the most interesting ones for
a brief oral presentation (5 minutes) at the Congress. Three outstanding posters will be awarded.
Važno! Studenti medicine, specijalizanti i znanstveni novaci koji
ispune prijavnicu za sudjelovanje i pošalju sažetak postera do
1.10.2013. oslobođeni su plaćanja kotizacije.
Ostali autori prihvaćenih postera plaćaju redovne kotizacije
koje trebaju biti uplaćene do 15.10.2013. kako bi sažeci bili
uvršteni u knjigu sažetaka Kongresa.
Please note: Medical students, residents and junior researchers
are exempt from registration fees if they submit their completed
registration form and poster abstract by the extended deadline
for abstract submission: October 1, 2013.
Other authors of accepted posters will have to pay their regular
registration fee by October 15, 2013 to include their abstracts
in the Congress Book of Abstracts.
Projekcije / Projections
Svim predavačima na raspolaganju je LCD projektor i laptop.
A LCD projector and a PC laptop will be available for presentations.
Izložbe i satelitski simpoziji / Exhibition and Satellite Symposia
Tijekom Kongresa u prostorima Hotela Sheraton bit će postav­
ljena izložba lijekova i medicinske opreme, a u program je mo­
guće uklopiti satelitske simpozije farmaceutskih tvrtki.
Exhibition of medicinal products and medical devices will be held
at the Sheraton Hotel during the Congress, and satellite symposia by pharmaceutical companies may be incorporated into
the Congress program.
25
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 26
Cijene i ostali detalji za izložbu, satelitske simpozije, oglašavanje
i sponzorstva nalaze se na posebnom letku u prilogu ove oba­
vijesti.
Rates and further details concerning exhibition, satellite symposia, advertising and sponsorships are included in a separate
leaflet enclosed with this Announcement.
Molimo tvrtke zainteresirane za ovakav način promidžbe svojih
proizvoda na Kongresu da se za sve informacije o zakupu izlož­
benog prostora, terminima predviđenim za satelitske simpozije,
oglašavanju i ostalim sponzorstvima, jave tehničkom organiza­
toru Kongresa:
All parties interested in promoting their products at the Congress
may contact the Technical Organizer for more detailed information about exhibition opportunities, satellite schedules, advertising and any other type of sponsorship:
O-Tours d.o.o.
Gajeva 6
HR­10000 Zagreb, Hrvatska
MB 1212397
tel. +385 1 4831 444
mobile +385 98 9805 716
fax + 385 1 4813 013
e­mail: [email protected]; [email protected]
www.otours.hr
www.zaklada-onkologija.hr
26
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 27
Registracija i kotizacija / Registration information
Registracijski desk / Registration desk
Radno vrijeme ureda za registraciju u Hotelu Sheraton /
Office hours at the Sheraton Hotel
Srijeda, 20.11.2013. /
Wednesday, Nov 20, 2013
16:00 – 20:00
Četvrtak, 21.11.2013. /
Thursday, Nov 21, 2013
08:30 – 19:00
Petak, 22.11.2013 ./
Friday, Nov 22, 2013
08:30 – 18:30
Subota, 23.11.2013. /
Saturday, Nov 23, 2013
08:30 – 12:00
Kotizacija / Registration fee
Liječnici /
Physicians
Medicinske
sestre /
Nurses
Dnevne
kotizacije /
Daily
Registration
Fee
do 24.09.2013. /
Until Sep 20, 2013
250 EUR
100 EUR
100 EUR
25.09. – 25.10.2013. /
Sep 25 – Oct 25, 2013
300 EUR
150 EUR
120 EUR
350 EUR
200 EUR
150 EUR
od 26.10.2013. i
na licu mjesta /
From Oct 26, 2013
on site
Radiološki
tehnolozi /
Radiologic
Technologists
90 EUR
27
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 28
Puna kotizacija uključuje: torbu s materijalima i knjigom sa­
žetaka, akreditaciju za sudjelovanje na svečanom otvorenju,
radnom dijelu Kongresa, satelitskim simpozijima, izložbi far­
maceutskih tvrtki, koktelu dobrodošlice, okrjepi tijekom stanki,
kongresnoj večeri, ručku.
Full registration fee includes: delegate’s bag with Congress materials, book of abstracts, admission to welcome reception, all scientific sessions, poster session, satellite symposia and commercial
exhibition, coffee breaks, congress dinner, and lunch.
Dnevna kotizacija uključuje: torbu s materijalima i knjigom
sažetaka, akreditaciju za sudjelovanje radnom dijelu Kongresa
izabranog dana, satelitskim simpozijima, izložbi farmaceutskih
tvrtki, okrjepi tijekom stanki.
Daily registration fee includes: delegate’s bag with Congress
materials, book of abstracts, admission to scientific sessions on
the chosen day, satellite symposia and commercial exhibition, coffee breaks.
Kotizacija za online prijenos kongresa / Registration fee for
Live Streaming
Za sve one koji osobno ne mogu doći osigurali smo prijenos Kon­
gresa uživo (live streaming) putem kojeg će moći aktivno sudje­
lovati, postavljati pitanja, komentirati i slično.
Svi nazočni sudionici kongresa dobit će brošuru s jedinstvenim
identifikacijskim brojem i uputama za naknadni pristup preda­
vanjima na internetu. Sadržaju kongresa korisnici mogu pri­
stupiti isključivo putem vouchera koji dostavljamo zajedno s
brošurom. Svi sadržaji dostupni su i putem pametnih telefona i
na web stranicama Zaklade onkologija .
For those who cannot attend there is an option to watch live
streams of the Congress and thus take an active part, ask questions,
comment and alike.
All Congress participants will get a brochure with an ID number
and instructions for subsequent Internet access to the entire event.
The conference presentation content will be accessible exclusively
by a voucher provided in the brochure. All content will also be available on smartphones and at the Oncology Foundation website.
Individualna
kotizacija /
Individual Fee
28
Liječnici / Physicians
Medicinske sestre /
Nurses
Radiološki tehnolozi /
Radiologic Technologists
100 EUR
50 EUR
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 29
Veselimo se što Vam možemo najaviti 2. regionalni kongres
„Suportivna terapija onkoloških bolesnika“, koji će se odr­
žati u Budvi od 1. do 4. 10. 2014. i koji će također imati online
verziju za sve sudionike koji ne mogu doći na skup.
We are pleased to announce that the 2nd Regional Congress on
Supportive Care for Cancer Patients will be held in Budva,
Montenegro on October 1-4, 2014, and that the online ver­
sion of this meeting, too, will be made available to those who
cannot attend.
Hotelski smještaj / Hotel Accommodation
Sudionici Kongresa bit će smješteni u hotelima Sheraton i Ar­
cotel u Zagrebu. / Congress participants will be accommodated
at the Sheraton and Arcotel Hotel in Zagreb.
Jednokrevetna soba /
Single room/Double
room with sole use
Nadoplata za
dvokrevetnu sobu / po
noćenju /
Supplement for double
occupancy per person
/ per night
SHERATON,
ZAGREB
136 EUR
25 EUR
ARCOTEL,
ZAGREB
62 EUR
12 EUR
Plaćanja / Payment
Način plaćanja kotizacije i hotelskog smještaja naveden je na
prijavnici koju trebaju popuniti svi, i aktivni i pasivni sudionici
kongresa.
Registration and accommodation fee payment terms are listed in
the registration form that should be completed by all active and
passive Congress participants.
29
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 30
Sve obavijesti za sudionike, izlagače, oglašivače i sponzore:
Information for all participants, exhibitors, advertisers and
sponsors at:
O-Tours d.o.o.
Gajeva 6
HR­10000 Zagreb, Hrvatska
MB 1212397
tel. +385 1 4831 444
mobile +385 98 9805 716
fax + 385 1 4813 013
e­mail: [email protected]; [email protected]
www.otours.hr
www.zaklada-onkologija.hr
Druga obavijest BOOK_kb:10x21 9/17/13 5:15 PM Page 31
Organizatori
Zaklada onkologija, Hrvatska i National Cancer Institute’s Center for
Global Health, US u suradnji s Hrvatskim društvom za internističku on­
kologiju, Hrvatskim društvom za endokrinološku onkologiju, Onkolo­
ško­hematološkim društvom Hrvatske udruge medicinskih sestara,
Hrvatskim društvom inženjera medicinske radiologije
Organizers
Oncology Foundation, Croatia and National Cancer Institute’s Center
for Global Health, US in cooperation with Croatian Society of Medical
Oncology, Croatian Society of Endocrine Oncology, Croatian Nurses As­
sociation ­ Society of Oncology and Hematology, Croatian Society of
Medical Radiology Engineers